These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 28577987)
1. ALCAR promote adult hippocampal neurogenesis by regulating cell-survival and cell death-related signals in rat model of Parkinson's disease like-phenotypes. Singh S; Mishra A; Mishra SK; Shukla S Neurochem Int; 2017 Sep; 108():388-396. PubMed ID: 28577987 [TBL] [Abstract][Full Text] [Related]
2. ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats. Singh S; Mishra A; Shukla S Mol Neurobiol; 2016 Sep; 53(7):4286-301. PubMed ID: 26223802 [TBL] [Abstract][Full Text] [Related]
3. MK-801 (Dizocilpine) Regulates Multiple Steps of Adult Hippocampal Neurogenesis and Alters Psychological Symptoms via Wnt/β-Catenin Signaling in Parkinsonian Rats. Singh S; Mishra A; Srivastava N; Shukla S ACS Chem Neurosci; 2017 Mar; 8(3):592-605. PubMed ID: 27977132 [TBL] [Abstract][Full Text] [Related]
4. Dopamine D1 receptor activation improves adult hippocampal neurogenesis and exerts anxiolytic and antidepressant-like effect via activation of Wnt/β-catenin pathways in rat model of Parkinson's disease. Mishra A; Singh S; Tiwari V; Parul ; Shukla S Neurochem Int; 2019 Jan; 122():170-186. PubMed ID: 30500462 [TBL] [Abstract][Full Text] [Related]
5. Acetyl-L-Carnitine via Upegulating Dopamine D1 Receptor and Attenuating Microglial Activation Prevents Neuronal Loss and Improves Memory Functions in Parkinsonian Rats. Singh S; Mishra A; Srivastava N; Shukla R; Shukla S Mol Neurobiol; 2018 Jan; 55(1):583-602. PubMed ID: 27975173 [TBL] [Abstract][Full Text] [Related]
6. Glycogen Synthase Kinase-3β Regulates Equilibrium Between Neurogenesis and Gliogenesis in Rat Model of Parkinson's Disease: a Crosstalk with Wnt and Notch Signaling. Singh S; Mishra A; Bharti S; Tiwari V; Singh J; Parul ; Shukla S Mol Neurobiol; 2018 Aug; 55(8):6500-6517. PubMed ID: 29327199 [TBL] [Abstract][Full Text] [Related]
7. Pioglitazone reduces mortality, prevents depressive-like behavior, and impacts hippocampal neurogenesis in the 6-OHDA model of Parkinson's disease in rats. Bonato JM; Bassani TB; Milani H; Vital MABF; de Oliveira RMW Exp Neurol; 2018 Feb; 300():188-200. PubMed ID: 29162435 [TBL] [Abstract][Full Text] [Related]
8. Dopamine receptor activation mitigates mitochondrial dysfunction and oxidative stress to enhance dopaminergic neurogenesis in 6-OHDA lesioned rats: A role of Wnt signalling. Mishra A; Singh S; Tiwari V; Chaturvedi S; Wahajuddin M; Shukla S Neurochem Int; 2019 Oct; 129():104463. PubMed ID: 31078578 [TBL] [Abstract][Full Text] [Related]
9. Acetyl-L-carnitine attenuates okadaic acid induced tau hyperphosphorylation and spatial memory impairment in rats. Yin YY; Liu H; Cong XB; Liu Z; Wang Q; Wang JZ; Zhu LQ J Alzheimers Dis; 2010; 19(2):735-46. PubMed ID: 20110616 [TBL] [Abstract][Full Text] [Related]
10. Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat. Afshin-Majd S; Bashiri K; Kiasalari Z; Baluchnejadmojarad T; Sedaghat R; Roghani M Biomed Pharmacother; 2017 May; 89():1-9. PubMed ID: 28199883 [TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of curcumin on hippocampal injury in 6-OHDA-induced Parkinson's disease rat. Yang J; Song S; Li J; Liang T Pathol Res Pract; 2014 Jun; 210(6):357-62. PubMed ID: 24642369 [TBL] [Abstract][Full Text] [Related]
12. Long-term treatment with L-DOPA or pramipexole affects adult neurogenesis and corresponding non-motor behavior in a mouse model of Parkinson's disease. Chiu WH; Depboylu C; Hermanns G; Maurer L; Windolph A; Oertel WH; Ries V; Höglinger GU Neuropharmacology; 2015 Aug; 95():367-76. PubMed ID: 25839898 [TBL] [Abstract][Full Text] [Related]
13. Selegiline normalizes, while l-DOPA sustains the increased number of dopamine neurons in the olfactory bulb in a 6-OHDA mouse model of Parkinson's disease. Chiu WH; Carlsson T; Depboylu C; Höglinger GU; Oertel WH; Ries V Neuropharmacology; 2014 Apr; 79():212-21. PubMed ID: 24291466 [TBL] [Abstract][Full Text] [Related]
14. Axin-2 knockdown promote mitochondrial biogenesis and dopaminergic neurogenesis by regulating Wnt/β-catenin signaling in rat model of Parkinson's disease. Singh S; Mishra A; Mohanbhai SJ; Tiwari V; Chaturvedi RK; Khurana S; Shukla S Free Radic Biol Med; 2018 Dec; 129():73-87. PubMed ID: 30176346 [TBL] [Abstract][Full Text] [Related]
15. Tetramethylpyrazine Analogue CXC195 Protects Against Dopaminergic Neuronal Apoptosis via Activation of PI3K/Akt/GSK3β Signaling Pathway in 6-OHDA-Induced Parkinson's Disease Mice. Chen L; Cheng L; Wei X; Yuan Z; Wu Y; Wang S; Ren Z; Liu X; Liu H Neurochem Res; 2017 Apr; 42(4):1141-1150. PubMed ID: 28005221 [TBL] [Abstract][Full Text] [Related]
16. Continuous intraventricular infusion of erythropoietin exerts neuroprotective/rescue effects upon Parkinson's disease model of rats with enhanced neurogenesis. Kadota T; Shingo T; Yasuhara T; Tajiri N; Kondo A; Morimoto T; Yuan WJ; Wang F; Baba T; Tokunaga K; Miyoshi Y; Date I Brain Res; 2009 Feb; 1254():120-7. PubMed ID: 19101524 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotective Effects of Acetyl-L-Carnitine Against Oxygen-Glucose Deprivation-Induced Neural Stem Cell Death. Bak SW; Choi H; Park HH; Lee KY; Lee YJ; Yoon MY; Koh SH Mol Neurobiol; 2016 Dec; 53(10):6644-6652. PubMed ID: 26643543 [TBL] [Abstract][Full Text] [Related]
18. Hypoxia-induced deactivation of NGF-mediated ERK1/2 signaling in hippocampal cells: neuroprotection by acetyl-L-carnitine. Barhwal K; Hota SK; Prasad D; Singh SB; Ilavazhagan G J Neurosci Res; 2008 Sep; 86(12):2705-21. PubMed ID: 18500755 [TBL] [Abstract][Full Text] [Related]
19. LPA signaling is required for dopaminergic neuron development and is reduced through low expression of the LPA1 receptor in a 6-OHDA lesion model of Parkinson's disease. Yang XY; Zhao EY; Zhuang WX; Sun FX; Han HL; Han HR; Lin ZJ; Pan ZF; Qu MH; Zeng XW; Ding Y Neurol Sci; 2015 Nov; 36(11):2027-33. PubMed ID: 26169757 [TBL] [Abstract][Full Text] [Related]
20. DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson's disease. Yu SJ; Wang Y; Shen H; Bae EK; Li Y; Sambamurti K; Tones MA; Zaleska MM; Hoffer BJ; Greig NH Geroscience; 2024 Oct; 46(5):4349-4371. PubMed ID: 38563864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]